Sampada Chemicals
In the Sep 2025 quarter, revenue rose 50.8% year on year to ₹28.63 Cr and net profit was ₹1.52 Cr, against ₹1.03 Cr a year earlier (compared with Sep 2024). Promoters held 72.26% of Sampada Chemicals in Dec 2025, unchanged from Sep 2025.
Peer Comparison
Financial Services › Finance › Other Financial Services
| ₹4,692.50 | 38.80 | 34,316 Cr | 10.49 | 0.77% | 25.25% | 31.04% | 4,420 Cr | 884 Cr | |
| — | — | 10,960 Cr | 1,266.83 | 0.00% | -85.77% | -48.08% | -7 Cr | -8 Cr | |
| ₹317.35 | 8.74 | 5,626 Cr | 2.15 | 0.00% | 20.96% | 32.93% | 2,420 Cr | 317 Cr | |
| — | 515.00 | 2,521 Cr | — | 0.02% | 0.00% | 0.00% | 174 Cr | 5 Cr | |
| ₹76.15 | 47.89 | 2,141 Cr | 15.93 | 0.00% | 24.84% | 28.77% | 259 Cr | 45 Cr | |
Sampada Chemicals (this company) | — | — | — | — | — | — | — | 85 Cr | 4 Cr |
| ₹129.20 | — | — | — | — | — | — | — | — | |
| ₹158.99 | — | — | — | — | — | — | — | — | |
| Median 8 companies | ₹158.99 | 43.35 | 5,626 Cr | 13.21 | 0.00% | 20.96% | 28.77% | 217 Cr | 25 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.54 times its book value
- Company's working capital requirements have reduced from 183 days to 93.9 days
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.49% over last 3 years.
- Company's cost of borrowing seems high
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Sales | 12.98 | 21.64 | 18.98 | 24.45 | 28.63 |
| Expenses | 11.49 | 19.08 | 16.64 | 23.01 | 26.33 |
| Operating Profit | 1.49 | 2.56 | 2.34 | 1.44 | 2.3 |
| OPM % | 11.48% | 11.83% | 12.33% | 5.89% | 8.03% |
| Other Income | 0.25 | 0.37 | 0.55 | 0.41 | 0.47 |
| Interest | 0.23 | 0.31 | 0.19 | 0.15 | 0.11 |
| Depreciation | 0.25 | 0.87 | 1.29 | 0.84 | 0.71 |
| PBT | 1.26 | 1.75 | 1.41 | 0.86 | 1.95 |
| Tax % | 24.6% | 28.57% | 26.24% | 23.26% | 22.05% |
| Net Profit | 0.96 | 1.26 | 1.03 | 0.67 | 1.52 |
| EPS (₹) | 1.92 | 1.84 | 1.5 | 0.98 | 2.21 |
Profit & Loss
| Particulars | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|
| Sales | 0.42 | 51.11 | 12.27 | 39.58 | 41.28 |
| Expenses | 0.24 | 47.63 | 1.91 | 36.93 | 41.41 |
| Operating Profit | 0.18 | 3.48 | 10.36 | 2.65 | -0.13 |
| OPM % | 42.86% | 6.81% | 84.43% | 6.7% | -0.31% |
| Other Income | 0 | 0 | 0 | 3.06 | 0.48 |
| Interest | 0.44 | 3.38 | 10.16 | 5.66 | 0.12 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.26 | 0.1 | 0.2 | 0.05 | 0.23 |
| Tax % | 0% | 0% | 5% | 0% | 17.39% |
| Net Profit | -0.26 | 0.1 | 0.19 | 0.05 | 0.19 |
| EPS (₹) | -0.52 | 0.2 | 0.38 | 0.1 | 0.38 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|
| Equity Capital | 4.98 | 4.98 | 4.98 | 4.98 | 4.98 |
| Reserves | 4.34 | 4.44 | 4.64 | 4.69 | 4.87 |
| Borrowings | 2.97 | 56.7 | 70.83 | 17.02 | 0.1 |
| Other Liabilities | 27.32 | 9.74 | 6.18 | 8.72 | 30.34 |
| Total Liabilities | 39.61 | 75.86 | 86.63 | 35.41 | 40.29 |
| Fixed Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 23.45 | 57.46 | 68.9 | 8.75 | 1.5 |
| Other Assets | 16.15 | 18.39 | 17.72 | 26.65 | 38.79 |
| Total Assets | 39.61 | 75.86 | 86.63 | 35.41 | 40.29 |
Cash Flow
| Particulars | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|
| Operating | — | -16.02 | 8.69 | 11.92 | 1.8 |
| Investing | — | -37.61 | -11.29 | 52.33 | 7.31 |
| Financing | — | 53.73 | 4.07 | -64.98 | -12.12 |
| Net Cash Flow | — | 0.1 | 1.47 | -0.73 | -3.01 |
| Free Cash Flow | — | -16.02 | 8.69 | 11.92 | 1.81 |
| CFO/EBITDA | — | -364 | 84 | 450 | -1,385 |
Ratios
| Particulars | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 183 | 24.26 | 2,391 | 35.94 | 0 |
| Days Payable | 1,493 | 79.37 | 1,030 | 49.88 | — |
| Cash Conversion Cycle | -1,311 | -55.11 | 1,361 | -13.93 | 0 |
| Working Capital Days | -9,707 | 61.06 | 297 | 158 | 93.9 |
| ROCE % | — | 8.88% | 14.14% | 10.66% | 1.91% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sampada Chemicals insights
39 extracted metrics + investor summaries across FY07–FY26.
Documents
Frequently Asked Questions about Sampada Chemicals
What does Sampada Chemicals Ltd do?
Where is Sampada Chemicals Ltd (506172) listed?
Which sector does Sampada Chemicals Ltd belong to?
Company Information
Sampada Chemicals Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in the finance and investments business in India
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506172.md for Sampada Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.